Showing results (361-370 of 454) with videos related to

Sort By:
Pageof 46
Biomedicines|April 23, 2022
Novel Translational Read-through-Inducing Drugs as a Therapeutic Option for Shwachman-Diamond SyndromeValentino Bezzerri, Laura Lentini, Martina Api, et al.
Frontiers in Oncology|January 1, 2024
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trialAndrea Pace, Giuseppe Lombardi, Veronica Villani, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial resultsSabino De Placido, Mario Giuliano, Francesco Schettini, et al.
Ecotoxicology and Environmental Safety|January 21, 2026
Chronic low-dose cadmium exposure accelerates the onset and metastasis of invasive mammary carcinoma and promotes immunosuppression in the tumor microenvironment in BALB-neuT miceChiara Focaccetti, Daniela Nardozi, Monica Benvenuto, et al.
Breast Cancer Research and Treatment|June 19, 2024
Male breast cancer: a multicenter study to provide a guide for proper managementGermana Lissidini, Luca Nicosia, Manuela Sargenti, et al.
Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.
Cancers|January 22, 2021
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future PerspectivesMichela Roberto, Antonio Astone, Andrea Botticelli, et al.
Therapeutic Advances in Medical Oncology|March 20, 2023
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapyGiovanna Garufi, Luisa Carbognin, Isabella Sperduti, et al.
La Radiologia Medica|March 21, 2025
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteriaCharlotte Trombadori, Edda Boccia, Elena Huong Tran, et al.
Targeted Oncology|September 24, 2022
Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 StudyMichelino De Laurentiis, Roberta Caputo, Manuelita Mazza, et al.
Pageof 46